Genotype-related Effects of PUFA

Nestlé

Status

Completed

Conditions

Healthy

Treatments

Dietary Supplement: Triple Strength Fish Oil

Study type

Interventional

Funder types

Industry

Identifiers

NCT02296385

11.16.NRC

Details and patient eligibility

About

To assess the bioefficacy of omega-3 fatty acids (provided by intake of fish oil supplements) depending on genotype of relevant factors in lipid metabolism

Full description

To assess the bioefficacy of omega-3 fatty acids (provided by intake of fish oil supplements) depending on genotype of relevant factors in lipid metabolism.

Enrollment

200 patients

Sex

All

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Healthy adult between 18 and 40 years of age
BMI between 18.5 and 30 kg/m2
Sedentary to moderate physical activity habits

Exclusion criteria

Concomitant treatment: Consumption of dietary supplements or any medication that can affect the study outcomes
Actively smoking
Suspected abuse of alcohol or illicit drugs
Significant illness within the two weeks prior to study start or any active systemic infection or medical condition that may require treatment during the study
Known or suspected medical condition related to coagulation
Subject who cannot be expected to comply with the study procedures
Currently participating or having participated in another clinical trial during the last 4 weeks prior to beginning of this study